Delpharm
Manufacturing · France · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Face 9 Quai Du 4 Septembre, Boulogne-Bil...Phone Number
+33 141091970Website
www.delpharm.comRevenue
$942.1 MillionIndustry
About Delpharm
Delpharm Org Chart
Is Delpharm your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Delpharm, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Delpharm is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Delpharm launches new products
Funding: Get notified immidiatlly once Delpharm has new funding data
Check if Delpharm has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Delpharm had a recent Job posting/layoffs
Earning: See what the market has to say on Delpharm recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Delpharm
Recommended Actions
Reach out to Masked Content who joined Delpharm as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Delpharm is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Delpharm is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Delpharm.
Delpharm Tech Stack
A closer look at the technologies used by Delpharm
Most Recent Scoops
Delpharm News & Media
AzurRx Announces Manufacturing Agreement with Delpharm for MS1819 Clinical Drug Product
NEW YORK, April 16, 2020 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that it has entered into a manufacturing agreement with Delpharm (“Delpharm”), a leading contract development manufacturing organization (CDMO), for the clinical drug product supply of its MS1819 therapy for exocrine pancreatic insufficiency (EPI).&nOverwhelming Success of First International NASH Day Paves Way for a Promising Edition In 2019
WASHINGTON and PARIS, June 14, 2018 /PRNewswire/ -- Following the great success of the First International NASH Day held on June 12, 2018, which has ignited enormous global enthusiasm beyond its 25 host cities and online, The NASH Education Program™ announces that: A second...Today, First International NASH Day: A First of its Kind Call to Action for Patients, Individuals at Risk, Medical Staff and Media
WASHINGTON, PARIS and LONDON, June 12, 2018 /PRNewswire/ -- Today is a first-of-its-kind disease awareness event, the First International NASH Day, paving the way for a better care for millions of NASH patients in the future. This ground breaking event aims at raising awareness about...D-1 Before First Ever International NASH Day: Detailed Program Announcement & Liver Forum Endorsement
WASHINGTON, PARIS, and LONDON, June 11, 2018 /PRNewswire/ -- Tomorrow is a first-of-its-kind disease awareness event, the First International NASH Day, paving the way for a better care for millions of NASH patients in the future. This ground breaking event aims at raising awareness...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Delpharm
Founded in 1988, based out of France, Delpharm is a European leader in contract manufacturing and development of medicines for pharmaceutical companies.... Read More